Nevro (NVRO) Competitors

AxoGen (NASDAQ:AXGN) and Nevro (NYSE:NVRO) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

Do institutionals & insiders hold more shares of AXGN or NVRO?

80.3% of AxoGen shares are held by institutional investors. Comparatively, 95.5% of Nevro shares are held by institutional investors. 7.0% of AxoGen shares are held by company insiders. Comparatively, 3.2% of Nevro shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Does the media favor AXGN or NVRO?

In the previous week, AxoGen had 7 more articles in the media than Nevro. MarketBeat recorded 10 mentions for AxoGen and 3 mentions for Nevro. AxoGen's average media sentiment score of 0.89 beat Nevro's score of 0.24 indicating that AxoGen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AxoGen	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Nevro	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more risk & volatility, AXGN or NVRO?

AxoGen has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Comparatively, Nevro has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500.

Does the MarketBeat Community prefer AXGN or NVRO?

Nevro received 47 more outperform votes than AxoGen when rated by MarketBeat users. However, 72.89% of users gave AxoGen an outperform vote while only 62.61% of users gave Nevro an outperform vote.

Company	Underperform	Outperform
AxoGen	Outperform Votes 457 72.89%	Underperform Votes 170 27.11%
Nevro	Outperform Votes 504 62.61%	Underperform Votes 301 37.39%

Is AXGN or NVRO more profitable?

AxoGen has a net margin of -7.91% compared to Nevro's net margin of -16.54%. AxoGen's return on equity of -14.91% beat Nevro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AxoGen	-7.91%	-14.91%	-7.49%
Nevro	-16.54%	-23.52%	-10.83%

Which has stronger valuation & earnings, AXGN or NVRO?

AxoGen has higher earnings, but lower revenue than Nevro. AxoGen is trading at a lower price-to-earnings ratio than Nevro, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AxoGen	$187.34M	4.50	-$21.72M	-$0.22	-86.32
Nevro	$408.52M	0.55	-$92.21M	-$3.05	-1.91

Do analysts recommend AXGN or NVRO?

AxoGen presently has a consensus target price of $22.60, indicating a potential upside of 19.01%. Nevro has a consensus target price of $6.43, indicating a potential upside of 10.02%. Given AxoGen's stronger consensus rating and higher probable upside, equities research analysts clearly believe AxoGen is more favorable than Nevro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AxoGen	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Nevro	2 Sell rating(s)	10 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.92

Summary

AxoGen beats Nevro on 14 of the 18 factors compared between the two stocks.